Returning to work after cancer
9 Sep 2017
Returning to work after cancer
Financial and ethical safety in cancer care
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
PACIFIC trial of durvalumab for stage III NSCLC
Cutting edge PET imaging in Cardiff
Emerging targets for the treatment of lung cancer
New treatment avenues in squamous cell carcinoma
Lung cancer advances beyond PD1
Identifying rare mutations in lung cancer
Current and future prospects in treating multiple myeloma
Developing technologies and the field of oncology
Haematology advances in review